Aqr Capital Management LLC Avrobio, Inc. Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.75 - $1.33 $275,379 - $488,340
-367,173 Reduced 73.73%
130,805 $120,000
Q1 2022

May 16, 2022
BUY
$1.29 - $4.04 $544,647 - $1.71 Million
422,207 Added 557.21%
497,978 $657,000
Q4 2021

Feb 14, 2022
BUY
$3.45 - $6.05 $261,409 - $458,414
75,771 New
75,771 $292,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email